Silibinin in Association With Concomitant Chemoradiotherapy and Maintenance Temozolomide in STAT3 Positive IDH Wild-type, Newly Diagnosed Glioblastoma Patients
Conditions
Glioblastoma · IDH Wild-type and STAT3-positive Glioblastoma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, BO, Italy
IRST Dino Amadori, Meldola, FC, Italy
Azienda Ospedaliero Universitaria Policlinico "G. Rodolico - San Marco ", Catania, Italia/Catania, Italy
Azienda Ospedaliera Universitaria - Careggi, Florence, Italia/FI, Italy
ARNAS G.Brotzu P.O Armando Businco, Cagliari, Italy/Cagliari, Italy
USL Nord Ovest Toscana - Livorno, Livorno, Italy/Livorno, Italy
Ospedale del Mare, ASL Napoli1 Centro, Naples, italy/Napoli, Italy
Istituto Oncologico Veneto, Padova, Italy/Padova, Italy
Istituto Neurologico Nazionale a Carattere Scientifico IRCCS - Fondazione Mondino, Pavia, Italy/Pavia, Italy
Azienda Ospedaliera Universitaria G.Martino, Messina, ME, Italy
Istituto Tumori Regina Elena IRCCS, Roma, RM, Italy
Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma, RM, Italy
Policlinico San Martino - Genova, Genova, Italy
Ospedale A. Manzoni Lecco, Lecco, Italy
Humanitas Cancer Center, Milan, Italy
IRCCS Ospedale Galeazzi Sant'Ambrogio, Milan, Italy